EUVIMEDEUVIMED entdecken
Fallbericht

Atypical presentations in an RTD patient and report of novel SLC52A3 and SLC52A2 mutations

Donya Sabeghi, Kolsoum InanlooRahatloo, Hanieh S Mirzadeh, Marzieh Khani, Hosein Shamshiri, Tarannomsadat Taghavi, Afagh Alavi, Reza Boostani, Seyed Hassan Tonekaboni, Javad Akhondian, Masoomah Ebrahimi, Najmeh Salehi und 2 weitere

Acta Neurologica Belgica · 2024

DOI: 10.1007/s13760-024-02598-7 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Acta Neurologica Belgica, 2024. Verfasst von Donya Sabeghi und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Biology, College of Science, University of Tehran, Enghelab Ave, Tehran, Iran. Hauptthemen laut MEDLINE: Mutation, Membrane Transport Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Tehran University of Medical Sciences and Health Services, Iran National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Riboflavin Transporter Deficiency (RTD) is a rare neurological disorder characterized by pontobulbar palsy, hearing loss, and motor cranial nerve involvement. SLC52A3 and SLC52A2 mutations are causes of RTD. SLC52A2 mutations are usually found in childhood onset cases. Fifteen Iranian RTD diagnosed patients without SLC52A2 mutations have been previously described. We aimed to identify causative mutations in two childhood cases. METHODS: We recruited patients with diagnosis of BVVL. Comprehensive clinical evaluations were performed on the patients. SLC52A3 and SLC52A2 genes were PCR-amplified and Sanger sequenced. Candidate disease causing variations were screened for segregation with disease status in the respective families and control individuals. RESULTS: A novel homozygous SLC52A3 mutation (p.Met1Val) and a heterozygous SLC52A2 mutation (p.Ala288Val) were both observed in one proband with typical RTD presentations. The aggregate of presentations in the early stages of disease in the second patient that included weakness in the lower extremities, absence of bulbar or hearing defects, prominent sensory polyneuropathy as evidenced in electrodiagnostic studies, and absence of sensory symptoms including sensory ataxia did not prompt immediate RTD diagnosis. Dysarthria and decreased hearing manifested later in the disease course. A novel homozygous SLC52A2 (p.Val314Met) mutation was identified. CONCLUSION: A literature search found recent reports of other atypical RTD presentations. These include MRI findings, speech understanding difficulties accompanied by normal hearing, anemia, and left ventricular non-compaction. Knowledge of unusual presentations lessens the chance of misdiagnosis or delayed RTD diagnosis which, in light of favorable effects of riboflavin supplementation, is of immense importance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutationMembrane Transport ProteinsHumansMaleBulbar Palsy, ProgressiveFemaleReceptors, G-Protein-CoupledChildPedigreeBasal Ganglia DiseasesHearing Loss, Sensorineural

Stichwörter der Autor:innen

SLC52A2SLC52A3Atypical presentationsBrown-Vialetto-Van Laere syndrome (BVVL)Riboflavin transporter deficiency disease (RTD)

Substanzen

Membrane Transport ProteinsSLC52A2 protein, humanSLC52A3 protein, humanReceptors, G-Protein-Coupled

Autor:innen und Institutionen

  • School of Biology, College of Science, University of Tehran, Enghelab Ave, Tehran, Iran.
  • School of Biology, College of Science, University of Tehran, Enghelab Ave, Tehran, Iran. inanloo@ut.ac.ir.
  • Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Shahid Fahmideh Children Hospital, Iran University of Medical Science, Tehran, Iran.
  • Iranian Neuromusclar Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Neurology, Tehran University of Medical Sciences, Tehran, Iran.

Förderung

  • Tehran University of Medical Sciences and Health Services
  • Iran National Science Foundation

Zitieren

APA

Sabeghi, D., InanlooRahatloo, K., Mirzadeh, H. S., Khani, M., Shamshiri, H., Taghavi, T., Alavi, A., Boostani, R., Tonekaboni, S. H., Akhondian, J., Ebrahimi, M., Salehi, N., Nafissi, S., & Elahi, E. (2024). Atypical presentations in an RTD patient and report of novel SLC52A3 and SLC52A2 mutations. Acta Neurologica Belgica. https://doi.org/10.1007/s13760-024-02598-7

Vancouver

Sabeghi D, InanlooRahatloo K, Mirzadeh HS, Khani M, Shamshiri H, Taghavi T, et al. Atypical presentations in an RTD patient and report of novel SLC52A3 and SLC52A2 mutations. Acta Neurologica Belgica. 2024. doi:10.1007/s13760-024-02598-7

BibTeX
@article{Sabeghi2024,
  author = {Sabeghi, Donya and InanlooRahatloo, Kolsoum and Mirzadeh, Hanieh S and Khani, Marzieh and Shamshiri, Hosein and Taghavi, Tarannomsadat and Alavi, Afagh and Boostani, Reza and Tonekaboni, Seyed Hassan and Akhondian, Javad and Ebrahimi, Masoomah and Salehi, Najmeh and Nafissi, Shahriar and Elahi, Elahe},
  title = {Atypical presentations in an RTD patient and report of novel SLC52A3 and SLC52A2 mutations},
  journal = {Acta Neurologica Belgica},
  year = {2024},
  doi = {10.1007/s13760-024-02598-7}
}
Kostenlos starten →